nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—ABCB1—Lisinopril—dilated cardiomyopathy	0.22	0.532	CbGbCtD
Amsacrine—ABCB1—Spironolactone—dilated cardiomyopathy	0.193	0.468	CbGbCtD
Amsacrine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.128	0.48	CbGeAlD
Amsacrine—KCNH2—endocardium—dilated cardiomyopathy	0.0662	0.248	CbGeAlD
Amsacrine—NCOA3—cardiac ventricle—dilated cardiomyopathy	0.0169	0.0634	CbGeAlD
Amsacrine—NCOA3—myocardium—dilated cardiomyopathy	0.0159	0.0596	CbGeAlD
Amsacrine—NCOA3—heart—dilated cardiomyopathy	0.0111	0.0416	CbGeAlD
Amsacrine—NCOA3—cardiac atrium—dilated cardiomyopathy	0.00951	0.0356	CbGeAlD
Amsacrine—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00684	0.0295	CcSEcCtD
Amsacrine—NCOA3—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00659	0.0804	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00645	0.0787	CbGpPWpGaD
Amsacrine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00592	0.0256	CcSEcCtD
Amsacrine—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.00591	1	CbGdCrCtD
Amsacrine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00557	0.0208	CbGeAlD
Amsacrine—KCNH2—myocardium—dilated cardiomyopathy	0.00524	0.0196	CbGeAlD
Amsacrine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00483	0.0209	CcSEcCtD
Amsacrine—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00469	0.0202	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00445	0.0542	CbGpPWpGaD
Amsacrine—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00443	0.0191	CcSEcCtD
Amsacrine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00439	0.019	CcSEcCtD
Amsacrine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00426	0.0184	CcSEcCtD
Amsacrine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00417	0.018	CcSEcCtD
Amsacrine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00408	0.0176	CcSEcCtD
Amsacrine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00371	0.016	CcSEcCtD
Amsacrine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00366	0.0158	CcSEcCtD
Amsacrine—KCNH2—heart—dilated cardiomyopathy	0.00366	0.0137	CbGeAlD
Amsacrine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00355	0.0153	CcSEcCtD
Amsacrine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00353	0.0152	CcSEcCtD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.00349	0.0425	CbGpPWpGaD
Amsacrine—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00343	0.0148	CcSEcCtD
Amsacrine—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.0033	0.0143	CcSEcCtD
Amsacrine—Purpura—Furosemide—dilated cardiomyopathy	0.00327	0.0141	CcSEcCtD
Amsacrine—Lethargy—Furosemide—dilated cardiomyopathy	0.00322	0.0139	CcSEcCtD
Amsacrine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00313	0.0117	CbGeAlD
Amsacrine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00313	0.0135	CcSEcCtD
Amsacrine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00308	0.0133	CcSEcCtD
Amsacrine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00296	0.0128	CcSEcCtD
Amsacrine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00287	0.0124	CcSEcCtD
Amsacrine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00279	0.0121	CcSEcCtD
Amsacrine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00264	0.0114	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00262	0.0319	CbGpPWpGaD
Amsacrine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.0025	0.0108	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00246	0.0106	CcSEcCtD
Amsacrine—Renal failure—Furosemide—dilated cardiomyopathy	0.00239	0.0103	CcSEcCtD
Amsacrine—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00235	0.0287	CbGpPWpGaD
Amsacrine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00235	0.0101	CcSEcCtD
Amsacrine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0023	0.00993	CcSEcCtD
Amsacrine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00227	0.0098	CcSEcCtD
Amsacrine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00227	0.00978	CcSEcCtD
Amsacrine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00225	0.00973	CcSEcCtD
Amsacrine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00222	0.00958	CcSEcCtD
Amsacrine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00216	0.00931	CcSEcCtD
Amsacrine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00214	0.00924	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00211	0.0257	CbGpPWpGaD
Amsacrine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0021	0.00907	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00198	0.0242	CbGpPWpGaD
Amsacrine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00198	0.00855	CcSEcCtD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—CD36—dilated cardiomyopathy	0.00197	0.0241	CbGpPWpGaD
Amsacrine—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00196	0.0239	CbGpPWpGaD
Amsacrine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00195	0.00842	CcSEcCtD
Amsacrine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00195	0.00842	CcSEcCtD
Amsacrine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00194	0.00839	CcSEcCtD
Amsacrine—Malnutrition—Furosemide—dilated cardiomyopathy	0.0019	0.00821	CcSEcCtD
Amsacrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00189	0.00814	CcSEcCtD
Amsacrine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00186	0.00804	CcSEcCtD
Amsacrine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00185	0.00799	CcSEcCtD
Amsacrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00181	0.00783	CcSEcCtD
Amsacrine—Rash—Spironolactone—dilated cardiomyopathy	0.0018	0.00776	CcSEcCtD
Amsacrine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0018	0.00775	CcSEcCtD
Amsacrine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00179	0.00774	CcSEcCtD
Amsacrine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00179	0.00773	CcSEcCtD
Amsacrine—Headache—Spironolactone—dilated cardiomyopathy	0.00179	0.00771	CcSEcCtD
Amsacrine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00178	0.00768	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00177	0.0216	CbGpPWpGaD
Amsacrine—Anaemia—Furosemide—dilated cardiomyopathy	0.00176	0.00758	CcSEcCtD
Amsacrine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00174	0.00751	CcSEcCtD
Amsacrine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00173	0.00745	CcSEcCtD
Amsacrine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0017	0.00735	CcSEcCtD
Amsacrine—Leukopenia—Furosemide—dilated cardiomyopathy	0.0017	0.00734	CcSEcCtD
Amsacrine—Nausea—Spironolactone—dilated cardiomyopathy	0.00169	0.00731	CcSEcCtD
Amsacrine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00167	0.0072	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00166	0.0203	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00166	0.0202	CbGpPWpGaD
Amsacrine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00164	0.00707	CcSEcCtD
Amsacrine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00162	0.00698	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00161	0.00694	CcSEcCtD
Amsacrine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.00693	CcSEcCtD
Amsacrine—ABCB1—heart—dilated cardiomyopathy	0.0016	0.006	CbGeAlD
Amsacrine—Confusional state—Furosemide—dilated cardiomyopathy	0.00156	0.00675	CcSEcCtD
Amsacrine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00152	0.00656	CcSEcCtD
Amsacrine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00151	0.0065	CcSEcCtD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0015	0.0183	CbGpPWpGaD
Amsacrine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.0015	0.0183	CbGpPWpGaD
Amsacrine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00149	0.00642	CcSEcCtD
Amsacrine—NCOA3—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00148	0.0181	CbGpPWpGaD
Amsacrine—Anorexia—Furosemide—dilated cardiomyopathy	0.00148	0.00638	CcSEcCtD
Amsacrine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00148	0.00637	CcSEcCtD
Amsacrine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00146	0.00632	CcSEcCtD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00145	0.0177	CbGpPWpGaD
Amsacrine—Hypotension—Furosemide—dilated cardiomyopathy	0.00145	0.00626	CcSEcCtD
Amsacrine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00145	0.00625	CcSEcCtD
Amsacrine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00144	0.0062	CcSEcCtD
Amsacrine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00143	0.00616	CcSEcCtD
Amsacrine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00139	0.00601	CcSEcCtD
Amsacrine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00135	0.00582	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—GJA1—dilated cardiomyopathy	0.00135	0.0164	CbGpPWpGaD
Amsacrine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00134	0.0058	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00578	CcSEcCtD
Amsacrine—Fatigue—Furosemide—dilated cardiomyopathy	0.00134	0.00577	CcSEcCtD
Amsacrine—NCOA3—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00134	0.0163	CbGpPWpGaD
Amsacrine—Pain—Furosemide—dilated cardiomyopathy	0.00133	0.00573	CcSEcCtD
Amsacrine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00132	0.00569	CcSEcCtD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00131	0.0159	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00129	0.0157	CbGpPWpGaD
Amsacrine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00128	0.00552	CcSEcCtD
Amsacrine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00128	0.00551	CcSEcCtD
Amsacrine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00127	0.00548	CcSEcCtD
Amsacrine—Urticaria—Furosemide—dilated cardiomyopathy	0.00123	0.00532	CcSEcCtD
Amsacrine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00123	0.00529	CcSEcCtD
Amsacrine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00123	0.00529	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00121	0.00521	CcSEcCtD
Amsacrine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00117	0.00507	CcSEcCtD
Amsacrine—Infection—Lisinopril—dilated cardiomyopathy	0.00116	0.00499	CcSEcCtD
Amsacrine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00114	0.00493	CcSEcCtD
Amsacrine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00114	0.00492	CcSEcCtD
Amsacrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00114	0.0049	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00113	0.0138	CbGpPWpGaD
Amsacrine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00113	0.00488	CcSEcCtD
Amsacrine—Asthenia—Furosemide—dilated cardiomyopathy	0.00111	0.0048	CcSEcCtD
Amsacrine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00111	0.00479	CcSEcCtD
Amsacrine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00109	0.0047	CcSEcCtD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.00108	0.0132	CbGpPWpGaD
Amsacrine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00106	0.00458	CcSEcCtD
Amsacrine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00105	0.00451	CcSEcCtD
Amsacrine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00104	0.00448	CcSEcCtD
Amsacrine—Dizziness—Furosemide—dilated cardiomyopathy	0.00103	0.00443	CcSEcCtD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	0.00103	0.0125	CbGpPWpGaD
Amsacrine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00101	0.00437	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.001	0.00434	CcSEcCtD
Amsacrine—Fatigue—Lisinopril—dilated cardiomyopathy	0.001	0.00433	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.001	0.0122	CbGpPWpGaD
Amsacrine—Pain—Lisinopril—dilated cardiomyopathy	0.000995	0.0043	CcSEcCtD
Amsacrine—Vomiting—Furosemide—dilated cardiomyopathy	0.000986	0.00426	CcSEcCtD
Amsacrine—Rash—Furosemide—dilated cardiomyopathy	0.000978	0.00422	CcSEcCtD
Amsacrine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000977	0.00422	CcSEcCtD
Amsacrine—Headache—Furosemide—dilated cardiomyopathy	0.000972	0.0042	CcSEcCtD
Amsacrine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000959	0.00414	CcSEcCtD
Amsacrine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000952	0.00411	CcSEcCtD
Amsacrine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000925	0.00399	CcSEcCtD
Amsacrine—Nausea—Furosemide—dilated cardiomyopathy	0.000921	0.00398	CcSEcCtD
Amsacrine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00092	0.00397	CcSEcCtD
Amsacrine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00092	0.00397	CcSEcCtD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.0009	0.011	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000878	0.0107	CbGpPWpGaD
Amsacrine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000857	0.0037	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000854	0.0104	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000836	0.0102	CbGpPWpGaD
Amsacrine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000835	0.00361	CcSEcCtD
Amsacrine—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000819	0.00999	CbGpPWpGaD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.000805	0.00981	CbGpPWpGaD
Amsacrine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000796	0.00344	CcSEcCtD
Amsacrine—NCOA3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000788	0.00961	CbGpPWpGaD
Amsacrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00077	0.00332	CcSEcCtD
Amsacrine—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.000767	0.00936	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.000765	0.00933	CbGpPWpGaD
Amsacrine—NCOA3—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	0.000753	0.00918	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TAZ—dilated cardiomyopathy	0.000741	0.00904	CbGpPWpGaD
Amsacrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00074	0.00319	CcSEcCtD
Amsacrine—Rash—Lisinopril—dilated cardiomyopathy	0.000734	0.00317	CcSEcCtD
Amsacrine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000733	0.00317	CcSEcCtD
Amsacrine—Headache—Lisinopril—dilated cardiomyopathy	0.000729	0.00315	CcSEcCtD
Amsacrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000691	0.00298	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.000684	0.00834	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.000682	0.00831	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00068	0.00829	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—SDHA—dilated cardiomyopathy	0.00067	0.00817	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.000641	0.00782	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	0.00061	0.00743	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000587	0.00716	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.000573	0.00699	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000523	0.00637	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000509	0.00621	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000493	0.00601	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.00049	0.00598	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.000466	0.00568	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CD36—dilated cardiomyopathy	0.000446	0.00544	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000424	0.00517	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—RAC1—dilated cardiomyopathy	0.00042	0.00512	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000417	0.00508	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000409	0.00499	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000406	0.00494	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000402	0.0049	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000398	0.00486	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000394	0.0048	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000386	0.0047	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	0.000363	0.00442	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000359	0.00437	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000357	0.00435	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000333	0.00406	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000299	0.00365	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	0.000298	0.00363	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—RAF1—dilated cardiomyopathy	0.000279	0.0034	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000278	0.00339	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000268	0.00327	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000261	0.00319	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000194	0.00236	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—EGFR—dilated cardiomyopathy	0.000191	0.00233	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	0.000186	0.00227	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPX1—dilated cardiomyopathy	0.000182	0.00222	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—dilated cardiomyopathy	0.000182	0.00222	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000179	0.00218	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CD36—dilated cardiomyopathy	0.000177	0.00216	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000173	0.00211	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000171	0.00208	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000168	0.00205	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000168	0.00205	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AGT—dilated cardiomyopathy	0.00016	0.00195	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000157	0.00191	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000137	0.00167	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000132	0.00161	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00013	0.00158	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000114	0.00139	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000114	0.00139	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00131	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000107	0.0013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000101	0.00123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	9.68e-05	0.00118	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	9.12e-05	0.00111	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	8.6e-05	0.00105	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.9e-05	0.000719	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.62e-05	0.000685	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.42e-05	0.000416	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.63e-05	0.000321	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.56e-05	0.000312	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.48e-05	0.000302	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.41e-05	0.000294	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.31e-05	0.000281	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.17e-05	0.000265	CbGpPWpGaD
